Alcoholic liver disease as a global health problem: Pathogenesis, diagnosis, and modern treatment approaches
Open Access
- 18 June 2025
- journal article
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 8,p. 100-112
Abstract
Alcoholic liver disease (ALD) is a global health issue that annually claims the lives of millions and leads to disabilities. According to the WHO, alcohol accounts for 5.9% of all deaths and 5.1% of global disease burden. In Russia, high alcohol consumption persists, with more than 1 million patients suffering from alcohol dependence. ALD includes a range of conditions, from steatosis to cirrhosis, the progression of which is influenced by factors such as dose, frequency, genetics, gender, and concomitant illnesses. The article details the pathogenesis of ALD, including toxic effects of alcohol, oxidative stress, and inflammation. Diagnostic methods are based on clinical data, laboratory tests, and imaging. Special attention is given to standardized alcohol dosages for risk assessments and safe consumption limits. Treatment of ALD requires a holistic approach, ranging from abstinence to medications like glucocorticoids and hepatoprotectants, and in severe cases, liver transplants. Essential phospholipids play (EFL) a crucial role in therapy. EFL restore hepatocyte membranes, reduce stress, suppress inflammation, prevent fibrosis. Studies have shown that EFL improves clinical and biochemical markers, such as bilirubin, liver enzyme activity (AsAT, ALAT), and lipid metabolism. The medication is well-tolerated and recommended for ALD treatment.Keywords
This publication has 41 references indexed in Scilit:
- Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide studyJournal of Hepatology, 2021
- Impact of COVID‐19 Pandemic on Liver Transplantation and Alcohol‐Associated Liver Disease in the USAHepatology, 2021
- Trajectory of Serum Bilirubin Predicts Spontaneous Recovery in a Real-World Cohort of Patients With Alcoholic HepatitisClinical Gastroenterology and Hepatology, 2021
- Beneficial effects of L-ornithine L-aspartate for prevention of overt hepatic encephalopathy in patients with cirrhosis: a systematic review with meta-analysisMetabolic Brain Disease, 2019
- Inflammatory pathways in alcoholic steatohepatitisJournal of Hepatology, 2019
- EASL Clinical Practice Guidelines: Management of alcohol-related liver diseaseJournal of Hepatology, 2018
- Risk for alcoholic liver cirrhosis after an initial hospital contact with alcohol problems: A nationwide prospective cohort studyHepatology, 2017
- EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosisJournal of Hepatology, 2015
- Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitisHepatology, 2015
- ESPEN Guidelines on Enteral Nutrition: Liver diseaseClinical Nutrition, 2006